Patent Application
20220219022
The subject invention is directed to a pulsed oxygen delivery system, and more particularly, to system and method for delivering a pulsed bolus of oxygen to the lungs of a user shortly after the start of inhalation in a closed breathing environment, such as, for example, a pressure suit worn by an astronaut that is required to support extravehicular activities outside of a spacecraft.
The pulsed delivery of supplemental oxygen to a user by way of a phase-dilution mask offers known benefits in terms of oxygen utilization efficiency as compared with a continuous flow of oxygen or that sources from the ambient environment, that being administered either at ground level conditions or most notably in low partial pressure environments. These benefits are due to a controlled bolus of oxygen being delivered directly to the lungs shortly after the start of inhalation rather than regions that do not support diffusion of oxygen to the blood stream. In addition, the delivery of the bolus of oxygen in a low ambient pressure environment is such that the volume of oxygen expands significantly to more completely fill the user's lungs, as compared with normal respiration. Such an effect is particularly noticeable at pressures less than 5.45 psia or 25,000 ft. equivalent.
The pulsed dispensing of supplemental and therapeutic oxygen is therefore widely practiced in the commercial aviation industry where the weight and volume occupied by the oxygen storage and supply system are important considerations, as disclosed for example in U.S. Pat. No. 8,733,352. That said, it would be beneficial to provide a pulsed oxygen delivery system for use in a closed breathing environment such as, for example, in a pressure suit worn by an astronaut performing extravehicular activity outside of a spacecraft.
The subject invention is directed to a new and useful pulsed oxygen delivery system for a closed breathing environment, a source of gaseous oxygen, a phase dilution type oronasal dispensing mask worn by a user in a closed breathing environment defined by a pressure suit, and a pulse control module for delivering a timed and metered bolus of oxygen from the source of gaseous oxygen to the oronasal dispensing mask upon demand by the user (i.e., shortly after the start of inhalation).
The pulse control module includes a pressure manifold having one or more breath sensors for sensing a breath taken by the user and one or more control valve for controlling the duration and amount of oxygen delivered to the dispensing mask. The source of gaseous oxygen includes a pressurized single use storage vessel or a refillable storage vessel, an initiator or mechanical valve for activating or otherwise establishing the flow of oxygen from the storage vessel and a regulator for managing the delivery of oxygen from the storage vessel to the pressure manifold.
The storage vessel includes a manifold body defining a first flow passage containing a frangible rupture disc, and the initiator includes an initiator body defining a second flow passage in fluid communication with the first flow passage. Means are provided for rupturing the rupture disc to initiate the flow of oxygen from the storage cylinder to the dispensing mask by way of a supply tube.
In one embodiment of the invention, the means for rupturing the rupture disc includes an initiator lance and a pyrotechnic charge for causing the lance to rupture the disc. Alternatively the means for initiating the flow of oxygen could be a mechanical or spring-loaded lance, or the storage vessel could include an oxygen supply valve that is manually or electrically moved from a closed positon to an open positon to initiate the flow of oxygen from the storage vessel. Preferably, the flow of oxygen from the storage vessel is initiated upon the sensing of a valid first breath by the breath sensor, and in the absence of a valid first breath the initiator is activated manually by the application of electrical power.
The pulse control module includes a microcontroller unit that is in communication with the pressure manifold, the source of gaseous oxygen and the pressure suit over an electronic interface. The microcontroller unit is programmed to monitor suit pressure and temperature, manifold pressure and temperature, and storage vessel pressure and temperature. The microcontroller unit is further programmed to manage the initiator or state of the oxygen supply valve, the one or more control valves and the one or more breath sensors. Preferably, the pulse control module is powered by primary and secondary power supplies that are isolated and protected from one another.
The subject invention is also directed to a method for delivering pulsed oxygen to an enclosed oxygen pressurized breathing environment, which involves providing a source of gaseous oxygen, connecting the source of gaseous oxygen to a phase dilution type oronasal dispensing mask worn by a user in a closed breathing environment defined by a pressure suit, and delivering a controlled bolus of oxygen from the source of gaseous oxygen to the oronasal dispensing mask upon demand by the user. Preferably, the controlled bolus of oxygen is delivered shortly after the start of inhalation.
It is envisioned that bolus volume can be controlled in one or more ways. For example, bolus volume could be controlled according to ambient pressure within the pressure suit, bolus volume could be controlled according to oxygen supply pressure and temperature, and/or bolus volume could be controlled according to a user's level of oxygen blood saturation.
Bolus volume could also be controlled so as to maintain a user's level of oxygen blood saturation in a target range equal to or greater than a defined baseline percentage specific to the user, so as to optimize the volume of oxygen that is required to be dispensed, as disclosed for example in commonly assigned U.S. Patent Application Publication No. 2015/0174359, the disclosure of which is incorporated herein by reference. In this regard, the level of blood oxygen saturation could also be measured by an oximeter or similar means and that information could be sent to the microcontroller unit to control the bolus of oxygen delivered to the user.
These and other features of the pulsed oxygen delivery system and method of the subject invention will become more readily apparent to those having ordinary skill in the art to which the subject invention appertains from the detailed description of the preferred embodiments taken in conjunction with the following brief description of the drawings.
So that those having ordinary skill in the art will readily understand how to make and use the pulsed oxygen delivery system of the subject invention without undue experimentation, preferred embodiments thereof will be described in detail herein below with reference to the figures wherein:
Referring now to the drawings wherein like reference numerals identify similar structural features or elements of the subject invention, there is illustrated in
As discussed in more detail below with reference to
The pulsed oxygen delivery system 100 is adapted and configured to respond to inhalation by delivering a precisely metered bolus volume (pulse) of oxygen directly to the lungs by way of mask 300 shortly after the start of inhalation in preference to regions that do not support diffusion of oxygen to the blood stream. As discussed in more detail below, this bolus volume of oxygen can be varied according to suit pressure conditions or in direct response to actively measured blood oxygen (pulse) saturation SpO2 levels of the user. The efficiency of the system depends on delivering the pulse early in the inhalation cycle. In order to maintain this level of efficiency, it is important to ensure that the inhalation is detected and pulse delivered in a reliable and timely manner.
Referring now to
The pulse control module 400 further includes a pressure manifold 410 and an electronic microcontroller unit 420. The pressure manifold 410 includes a manifold housing 460 that acts as a plenum on the circuit board 425 for distributing oxygen to the user. The manifold housing 460 has an inlet 462 for receiving oxygen from the supply source 200 and a pair of outlet fittings 464a, 464b for communicating with the oronasal mask 300 by way of associated tubing.
The pressure manifold 410 further includes a pair of breath sensors 412a, 412b, which act as a vacuum pressure switches for sensing a breath taken by the user, and a pair of solenoid control valves 414a, 414b for controlling the duration and amount of oxygen delivered to the dispensing mask. Inhalation demand is sensed by the breath sensors 412a, 412b as a small differential pressure in the supply tube created by inhaling through the mask 300. The solenoid control valves 414a, 414b are characterized as 2-way, normally closed with a nominal 20 ms on-off response time. The paired breath sensors and control valves provide for parallel redundant operation of the system.
The effective bolus volume is determined by the duration that the dispensing solenoid valve 414a, 414b is open. Upon sensing a breath, the controller 400 opens the solenoid valve 414a, 414b to provide a small, metered pulse of oxygen. The controller 400 meters the quantity of oxygen by adjusting the duration that the valve is powered open. This duration is calculated based on the results of a series of equations or by a look up table that reflects the characteristics and response of the dispensing system, but is controlled based on the current suit pressure or the user's SpO2 levels.
With continuing reference to
Manifold gas temperature and absolute pressure is monitored by an integrated circuit sensor 415 that is mounted on the controller printed circuit board 425. A sensing port 417 in the pressure manifold 410 transmits manifold gas directly to that sensor. An LED status indicator array 418 is integrated into the controller board 425, which illuminates to indicate that a breath was taken on the mask 300 and oxygen was dispensed to that mask.
Referring now to
The storage vessel 212 is preferably a non-refillable, single use device, which may be manufactured from a welded stainless steel liner that is structurally supported by a Carbon Fiber Epoxy composite wrapping that is intended to be resistant to outgassing in a persistent low ambient pressure environment. The breathing gas contained in the storage vessel 212 is preferably an oxygen/helium mixture comprising 99.5% oxygen and between 0.25% and 0.50% helium. The helium is used as a challenge gas to perform acceptance leakage tests that verifies the seal between the initiator 214 and the storage vessel 212. The resulting breathing gas mixture provides satisfactory supplemental oxygen for hypoxia protection.
As best seen in
Referring to
As shown in
Alternatively the mechanism for initiating the flow of oxygen could be a mechanical or spring loaded-lance, or the storage vessel 212 could include a mechanical or solenoid operated valve that is mechanically or electrically moved from a closed positon to an open positon to initiate the flow of oxygen from the storage vessel 212. Preferably, the flow of oxygen from the storage vessel 212 is initiated upon the sensing of a valid first breath by the breath sensor, and in the absence of a valid first breath the initiator 214 is activated.
More particularly, during the activation of the initiator 214, the control module 400 monitors the electrical resistance of the initiator bridge circuit as a means of verifying whether the initiator 214 has been fired successfully. If the control module 400 determines that the initiator has not been fired, the control module 400 will continue to attempt to activate a further 2 times at 5 seconds intervals, after which the initiator 214 is activated by the application of electrical power.
Referring now to
The pulse control module 400 is powered continuously by primary and secondary 28 VDC power supplies 450a, 450b, although other voltages could be used. Preferably, power supplies 450a, 450b are isolated and protected from one another by way of an input power sense and conditioning circuit 455 monitored by the MCU 420. Moreover, each power input is transient suppression protected and diode isolated to support segregation requirements at the suit level. These supplies are configured such that any combination of inputs can be used to provide electrical power to the controller 420 by way of a power connector 452, shown in
The oxygen supply system 100 further includes a Built-In-Test (BIT) functionality. In the event that a valid first breath is not detected in the first 15 seconds after power is applied to the oxygen control module 400 (it is normally unpowered), the oxygen control module 400 will perform a BIT to verify, where feasible, functional aspects of the control module 400 relative to its intended use and operation. If a valid breath is sensed at any time thereafter, the control module 400 will respond by proceeding to activate the initiator 214 to start the flow of oxygen to the pressure manifold 410 of the control module 400. If the supply of oxygen is not controlled by the initiator 214 but using a mechanical or electrical valve, the control module 400 will either signal to electrically open the valve based on the sensing of a valid breath, or act on the presence of oxygen in the case of a mechanical valve. A BIT indicator 424 is provided on the printed circuit board 425, which is illuminated in response to the outcome of the test and it send a message via the CAN connector 426 to report on the condition of the oxygen supply system 100.
The subject invention is also directed to a method for delivering pulsed oxygen to a closed breathing environment, which involves providing a source of gaseous oxygen 200, connecting the source of gaseous oxygen to a phase dilution type oronasal dispensing mask 300 worn by a user in a closed breathing environment defined by a pressure suit 10, and delivering a controlled bolus of oxygen from the source of gaseous oxygen 200 to the oronasal dispensing mask 300 upon demand by the user, wherein the controlled bolus of oxygen is delivered shortly after the start of inhalation.
A phase dilution type oronasal dispensing mask 300 is illustrated in
It is envisioned that bolus volume can be controlled in one or more ways. For example, bolus volume could be controlled according to ambient pressure within the pressure suit, bolus volume could be controlled according to oxygen supply pressure and temperature, and/or bolus volume could be controlled according to a user's level of oxygen blood saturation. Bolus volume could, in addition, also be controlled so as to maintain a user's level of oxygen blood saturation in a target range equal to or greater than a defined baseline percentage specific to the user, so as to optimize the volume of oxygen that is required to be dispensed, as disclosed in U.S. Patent Application Publication No. 2015/0174359. In this regard, the level of blood oxygen saturation could also be measured by an oximeter or similar means and that information could be sent to the microcontroller unit to control the bolus of oxygen delivered to the user.
In situations where the user's measured SpO2 is available as a control input, the oxygen controller 400 employs an operation mode pulse-width look-up table stored in non-volatile memory (NVM) resident in the microprocessor 420. The pulse-width look-up table is indexed such that each SpO2 entry received represents an increment reflecting the desired SpO2 baseline specific to the user. The oxygen controller 400 activates the solenoid valve 414a, 414b for the pulse-width duration determined from the look-up table value corresponding to the index defined from the SpO2 index value received by CAN bus 445. Those skilled in the art will readily appreciate that the paired solenoid valves 414a, 414b are provided for parallel redundancy. In use, only one valve is needed, while the other remains as a “hot” spare if needed.
Compared with unassisted breathing from an ambient oxygen environment, as is the case in current suit systems, the utilization of a pulse delivery of oxygen as disclosed herein is seen as an opportunity to provide the following benefits: offset or improve upon any existing oxygen partial pressure deficiency relative to ground conditions; require less oxygen to be carried to support breathing/workload requirements compared with the current approach; and lower suit pressures which may as a result have a corresponding benefit of reducing physical workload thus leading to a reduction in heat generated and CO2 produced by the occupant that must be accounted for by the environmental control systems and thus, achieve as a result a corresponding reduction in oxygen fire hazard and risk within the suit where the flammability of fuel-like materials is a function of oxygen pressure.
While the subject disclosure has been shown and described with reference to preferred embodiments, those skilled in the art will readily appreciate that changes and/or modifications may be made thereto without departing from the scope of the subject disclosure.
